Align Technology’s (ALGN) robust product line, consistent focus on international markets and strategic alliances bolster our confidence in the stock. The stock carries a Zacks Rank #2 (Buy) currently.Align Technology is strategically capturing the growing malocclusion market, one of the most prevalent clinical dental conditions in the world. According to Align Technology’s May 2023 data, the condition currently affects approximately 60% to 75% of the global population. The company estimates that there are a ...